Zipratic 40 Capsule
Zipratic 40 Capsule is used in the treatment of schizophrenia (a mental disorder that can result in hallucinations or delusions and also adversely affects a person’s ability to think and behave) and mania.
Zipratic 40 Capsule
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Zipratic 40 Capsule is used in the treatment of schizophrenia (a mental disorder that can result in hallucinations or delusions and also adversely affects a person’s ability to think and behave) and mania.
Zipratic 40 Capsule is used in the treatment of schizophrenia (a mental disorder that can result in hallucinations or delusions and also adversely affects a person’s ability to think and behave) and mania.
Zipratic 40 Capsule should be taken with food, preferably at the same time, each day. Take this in the dose and duration as advised by your doctor and if you have missed a dose, take it as soon as you remember. It is important that this medication is not stopped suddenly without talking to your doctor as it may worsen your symptoms. However, discontinue this medicine immediately if you experience Neuroleptic malignant syndrome (NMS), characterized by fever, muscle rigidity, and altered consciousness or seizures.
Some common side effects of this medicine include headache, nausea, vomiting, abnormal vision, and dystonia (involuntary muscle contractions). Initially, this medicine may cause a sudden drop in blood pressure when you change positions, so it is better to rise slowly if you have been sitting or lying down. It also causes dizziness and sleepiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you. This medicine may increase your weight but, modifying your lifestyle by having a healthy diet and exercising regularly can reduce this side effect.
You should be cautious while using this medicine as it may increase the risk of developing diabetes, so it is better to monitor glucose regularly. Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression, or suicidal thoughts while taking this medicine.
03Uses
Mania
Schizophrenia
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Zipratic 40 Capsule is to be taken with food.
05How It Works
Zipratic 40 Capsule is an atypical antipsychotic. It works by modulating the action of certain chemical messengers in the brain that affect thoughts.
06What If You Miss A Dose?
Q: What if you forget to take Zipratic Capsule?
A: If you miss a dose of Zipratic 40 Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Mania
Mania means extremely excited or elevated mood. Zipratic 40 Capsule helps calm the mood and relax the nerves. This stabilises the mood and prevents the symptoms of mania from recurring again. Taking Zipratic 40 Capsule will ensure that you have a better social life and are able to do daily activities more comfortably.
08Side Effects
Headache
Nausea
Vomiting
Sleepiness
Abnormal vision
Dystonia (involuntary muscle contractions)
Akathisia (inability to stay still)
Weakness
Parkinsonism
Dizziness
Respiratory tract infection
09Safety Information
Alcohol:UNSAFE
It is unsafe to consume alcohol with Zipratic 40 Capsule.
Pregnancy:CONSULT YOUR DOCTOR
Zipratic 40 Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Zipratic 40 Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving:UNSAFE
Zipratic 40 Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.Caution is advised when driving or operating machinery.
Kidney:SAFE IF PRESCRIBED
Zipratic 40 Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Zipratic 40 Capsule may not be needed in these patients. Please consult your doctor.
Liver:CAUTION
Zipratic 40 Capsule should be used with caution in patients with liver disease. Dose adjustment of Zipratic 40 Capsule may be needed. Please consult your doctor.
10Drug Tips
It should be taken with food.
Use caution while driving or doing anything that requires concentration as Zipratic 40 Capsule may cause dizziness and sleepiness.
Avoid consuming alcohol when taking medicine as it may cause excessive drowsiness.
Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression, or suicidal thoughts or behavior.
Do not stop taking Zipratic 40 Capsule without talking to your doctor first as it may cause a worsening of symptoms.
References
Sources and references
Stahl SM, editor. Ziprasidone. In: Stahl’s Essential Pschopharmacology: Prescriber’s Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 743-49.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1515-16.
Ziprasidone. New York, New York: Pfizer Inc.; 2001 [revised Dec. 2014]. [Accessed 23 Jan. 2019] (online) Available from: View
Miceli JJ, Glue P, Alderman J, Wilner K, et al. The effect of food on the absorption of oral ziprasidone. Psychopharmacol Bull. 2007;40(3):58-68. [Accessed 19 Mar. 2019] (online) Avaialble from: View
Ziprasidone. New York, New York: Pfizer Inc.; 2001 [revised Aug. 2015]. [Accessed 19 Mar. 2019] (online) Available from: View
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Ziprasidone. [Updated 2018 Oct 31]. [Accessed 20 Feb. 2020] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from: View
Ziprasidone [Drug Label]. New York, NY: Roerig; 2008. [Accessed 25 Jul. 2024] (online) Available from: View
